Morphle Labs makes robotic machines for pathology laboratories: slide scanners that turn glass microscope slides into digital images, and a robotic tissue-cutting machine. It describes its aim as removing bottlenecks in cancer diagnosis.
Morphle Labs, based in Bengaluru, describes its mission as 'solving bottlenecks in cancer diagnostics'. It makes the MorphoLens range of whole-slide scanners (single-slide to 400-slide batch, at 40x and, for haematology, 100x oil), the HemoLens scanner for blood smears and bone marrow aspirates, the Robotome robotic microtome for cutting tissue sections, and RoboReq, software that reads handwritten requisition forms. Its scanners handle histopathology, immunohistochemistry (including ER, PR, Ki67 and HER2 stains) and cytology, as well as non-cancer work such as malaria smears. The company states ISO 13485 certification, CE marking under the EU IVDR for MorphoLens and Robotome, and FDA establishment registration. Y Combinator lists it as founded in 2017 with a team of 65, in the Winter 2020 batch.
Shares Y Combinator, Digital pathology & AI, Histopathology & immunohistochemistry.
Shares Y Combinator, Digital pathology & AI, Histopathology & immunohistochemistry.
Shares Digital pathology & AI, Histopathology & immunohistochemistry.
Shares Y Combinator, Digital pathology & AI.
Shares Y Combinator, Digital pathology & AI.
Shares Digital pathology & AI, Histopathology & immunohistochemistry.
Shares Digital pathology & AI, Histopathology & immunohistochemistry.
Shares Digital pathology & AI, Histopathology & immunohistochemistry.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/